Table 4

Changes in metabolic syndrome and metabolic parameters after changes in body weight for all groups combined (SMS+, SMS−, and CAU). Differences were tested with multilevel logistic regression analyses for categorical variables and with multilevel linear regression analyses for continuous variables, combined with a bootstrap procedure in case of a non-normal distribution.

Changes in body weight (all groups combined)
5% weight gain5% weight loss10% weight lossEstimate (s.e.)P value
Metabolic syndrome (%)14.1−13.2−23.80.114 (0.028)<0.001
 Waist ≥ 88 cm (%)5.5−9.2−22.90.139 (0.033)<0.001
 Glucose ≥ 6.1 mmol/L (%)2.7−1.7−2.70.105 (0.061)0.090
 BP ≥ 129/84 mmHg (%)6.9−6.1−11.40.061 (0.025)0.017
 HDL < 1.3 mmol/L (%)1.4−1.9−4.40.066 (0.044)0.133
 TG ≥ 1.7 mmol/L (%)5.5−4.9−9.00.054 (0.027)0.047
Insulin resistance (%)9.2−11.5−24.20.103 (0.025)<0.001
Metabolic parameters
 cMetS z-score0.22−0.22−0.430.043 (0.005)<0.001
 HOMA-IR0.42−0.42−0.830.083 (0.017)<0.001
 SBP (mmHg)2−2−40.373 (0.101)0.001
 DBP (mmHg)2−2−30.333 (0.076)<0.001
 Waist (cm)4.1−4.1−8.30.827 (0.080)<0.001
 Glucose (mmol/L)0.1−0.1−0.20.015 (0.004)0.001
 Insulin (pmol/L)11−11−222.187 (0.484)<0.001
 Cholesterol (mmol/L)0.1−0.1−0.20.022 (0.006)0.001
 HDL (mmol/L)−0.020.020.05−0.005 (0.002)0.006
 LDL (mmol/L)0.08−0.08−0.170.017 (0.005)0.005
 TG (mmol/L)0.12−0.12−0.230.023 (0.005)<0.001
Changes in body weight (all groups combined)
5% weight gain5% weight loss10% weight lossEstimate (s.e.)P value
Metabolic syndrome (%)14.1−13.2−23.80.114 (0.028)<0.001
 Waist ≥ 88 cm (%)5.5−9.2−22.90.139 (0.033)<0.001
 Glucose ≥ 6.1 mmol/L (%)2.7−1.7−2.70.105 (0.061)0.090
 BP ≥ 129/84 mmHg (%)6.9−6.1−11.40.061 (0.025)0.017
 HDL < 1.3 mmol/L (%)1.4−1.9−4.40.066 (0.044)0.133
 TG ≥ 1.7 mmol/L (%)5.5−4.9−9.00.054 (0.027)0.047
Insulin resistance (%)9.2−11.5−24.20.103 (0.025)<0.001
Metabolic parameters
 cMetS z-score0.22−0.22−0.430.043 (0.005)<0.001
 HOMA-IR0.42−0.42−0.830.083 (0.017)<0.001
 SBP (mmHg)2−2−40.373 (0.101)0.001
 DBP (mmHg)2−2−30.333 (0.076)<0.001
 Waist (cm)4.1−4.1−8.30.827 (0.080)<0.001
 Glucose (mmol/L)0.1−0.1−0.20.015 (0.004)0.001
 Insulin (pmol/L)11−11−222.187 (0.484)<0.001
 Cholesterol (mmol/L)0.1−0.1−0.20.022 (0.006)0.001
 HDL (mmol/L)−0.020.020.05−0.005 (0.002)0.006
 LDL (mmol/L)0.08−0.08−0.170.017 (0.005)0.005
 TG (mmol/L)0.12−0.12−0.230.023 (0.005)<0.001

BP, blood pressure; CAU, care as usual; cMetS z-score, continuous metabolic syndrome z-score; DBP, diastolic blood pressure; HDL, high-density lipoprotein; HOMA-IR, homeostatic model assessment for insulin resistance; LDL, low-density lipoprotein; SBP, systolic blood pressure; SMS−, lifestyle intervention without SMS support; SMS+, lifestyle intervention with SMS support; TG, triglyceride.

Statistically significant values (P<0.05) are presented in bold.

Table 4

Changes in metabolic syndrome and metabolic parameters after changes in body weight for all groups combined (SMS+, SMS−, and CAU). Differences were tested with multilevel logistic regression analyses for categorical variables and with multilevel linear regression analyses for continuous variables, combined with a bootstrap procedure in case of a non-normal distribution.

Changes in body weight (all groups combined)
5% weight gain5% weight loss10% weight lossEstimate (s.e.)P value
Metabolic syndrome (%)14.1−13.2−23.80.114 (0.028)<0.001
 Waist ≥ 88 cm (%)5.5−9.2−22.90.139 (0.033)<0.001
 Glucose ≥ 6.1 mmol/L (%)2.7−1.7−2.70.105 (0.061)0.090
 BP ≥ 129/84 mmHg (%)6.9−6.1−11.40.061 (0.025)0.017
 HDL < 1.3 mmol/L (%)1.4−1.9−4.40.066 (0.044)0.133
 TG ≥ 1.7 mmol/L (%)5.5−4.9−9.00.054 (0.027)0.047
Insulin resistance (%)9.2−11.5−24.20.103 (0.025)<0.001
Metabolic parameters
 cMetS z-score0.22−0.22−0.430.043 (0.005)<0.001
 HOMA-IR0.42−0.42−0.830.083 (0.017)<0.001
 SBP (mmHg)2−2−40.373 (0.101)0.001
 DBP (mmHg)2−2−30.333 (0.076)<0.001
 Waist (cm)4.1−4.1−8.30.827 (0.080)<0.001
 Glucose (mmol/L)0.1−0.1−0.20.015 (0.004)0.001
 Insulin (pmol/L)11−11−222.187 (0.484)<0.001
 Cholesterol (mmol/L)0.1−0.1−0.20.022 (0.006)0.001
 HDL (mmol/L)−0.020.020.05−0.005 (0.002)0.006
 LDL (mmol/L)0.08−0.08−0.170.017 (0.005)0.005
 TG (mmol/L)0.12−0.12−0.230.023 (0.005)<0.001
Changes in body weight (all groups combined)
5% weight gain5% weight loss10% weight lossEstimate (s.e.)P value
Metabolic syndrome (%)14.1−13.2−23.80.114 (0.028)<0.001
 Waist ≥ 88 cm (%)5.5−9.2−22.90.139 (0.033)<0.001
 Glucose ≥ 6.1 mmol/L (%)2.7−1.7−2.70.105 (0.061)0.090
 BP ≥ 129/84 mmHg (%)6.9−6.1−11.40.061 (0.025)0.017
 HDL < 1.3 mmol/L (%)1.4−1.9−4.40.066 (0.044)0.133
 TG ≥ 1.7 mmol/L (%)5.5−4.9−9.00.054 (0.027)0.047
Insulin resistance (%)9.2−11.5−24.20.103 (0.025)<0.001
Metabolic parameters
 cMetS z-score0.22−0.22−0.430.043 (0.005)<0.001
 HOMA-IR0.42−0.42−0.830.083 (0.017)<0.001
 SBP (mmHg)2−2−40.373 (0.101)0.001
 DBP (mmHg)2−2−30.333 (0.076)<0.001
 Waist (cm)4.1−4.1−8.30.827 (0.080)<0.001
 Glucose (mmol/L)0.1−0.1−0.20.015 (0.004)0.001
 Insulin (pmol/L)11−11−222.187 (0.484)<0.001
 Cholesterol (mmol/L)0.1−0.1−0.20.022 (0.006)0.001
 HDL (mmol/L)−0.020.020.05−0.005 (0.002)0.006
 LDL (mmol/L)0.08−0.08−0.170.017 (0.005)0.005
 TG (mmol/L)0.12−0.12−0.230.023 (0.005)<0.001

BP, blood pressure; CAU, care as usual; cMetS z-score, continuous metabolic syndrome z-score; DBP, diastolic blood pressure; HDL, high-density lipoprotein; HOMA-IR, homeostatic model assessment for insulin resistance; LDL, low-density lipoprotein; SBP, systolic blood pressure; SMS−, lifestyle intervention without SMS support; SMS+, lifestyle intervention with SMS support; TG, triglyceride.

Statistically significant values (P<0.05) are presented in bold.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close